Chemical engineering

AIChE and IChemE Announce Webinar Series and Annual Conference to Advance Hydrogen as an Energy Carrier

Retrieved on: 
Monday, March 11, 2024

The webinar series will launch in the second quarter of 2024, and will include contributions from AIChE and IChemE.

Key Points: 
  • The webinar series will launch in the second quarter of 2024, and will include contributions from AIChE and IChemE.
  • Among the first offerings will be a session that considers “myths and realities” related to hydrogen and its use.
  • In 2025, the organizations will debut a joint annual conference focusing on the production and use of hydrogen.
  • The 2025 Hydrogen Technologies and Applications Conference will be held in North America, with the 2026 Conference being scheduled to take place in the UK.

Interfor Appoints Christina Sistrunk to its Board of Directors

Retrieved on: 
Wednesday, March 6, 2024

BURNABY, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) is pleased to announce the appointment of Christina Sistrunk of Lumberton, Mississippi as an independent director of the Company.

Key Points: 
  • BURNABY, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) is pleased to announce the appointment of Christina Sistrunk of Lumberton, Mississippi as an independent director of the Company.
  • Ms. Sistrunk served as President and CEO of Aera Energy, LLC (an independent upstream oil and gas company) between 2015 and 2020.
  • Ms. Sistrunk currently serves on the External Advisory Council for The Ohio State University College of Engineering, and on the Advisory Board for Renewell Energy.
  • Her appointment increases the percentage of women directors on Interfor’s Board, to 30%.

Acrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA, Experienced Board Member and Healthcare Investor, to its Board of Directors

Retrieved on: 
Monday, March 4, 2024

Dr. Palani added, “Acrivon is an entirely science-based company and its AP3 platform is a ground-breaking approach which is broadly applicable across drug discovery and development with significant unrealized potential -- not only in oncology but also in other areas including autoimmune and metabolic disorders, as dysregulated signaling ultimately underlies all diseases. The company currently is focused on oncology with a highly differentiated profile in this space. I am excited to join a distinguished board and support the full realization of the potential of the platform applied to the company’s current pipeline and beyond.”

Key Points: 
  • “Santhosh previously served as an advisor to Acrivon and has a deep understanding and appreciation of the breadth and novelty of our next generation precision medicine platform,” said Peter Blume-Jensen, M.D., Ph.D., chief executive officer, president, and founder of Acrivon Therapeutics.
  • At PFM, Dr. Palani led public and private biotechnology investments, and served on the board of companies in the cell therapy and gene editing fields.
  • Prior to Cowen, Dr. Palani was in oncology drug development at Pfizer Inc. and Takeda Pharmaceuticals.
  • I am excited to join a distinguished board and support the full realization of the potential of the platform applied to the company’s current pipeline and beyond.”

Spencer Fane Enters Nation’s Second Largest Legal Market with Patent Litigation Group

Retrieved on: 
Wednesday, February 28, 2024

The trio joins the firm’s growing Intellectual Property practice while also giving Spencer Fane a foothold in the second-largest legal market in the U.S.

Key Points: 
  • The trio joins the firm’s growing Intellectual Property practice while also giving Spencer Fane a foothold in the second-largest legal market in the U.S.
  • The group joins a Spencer Fane IP team that possesses both the technical knowledge and legal experience necessary to protect inventors, entrepreneurs, and businesses of all sizes.
  • She has litigated patent cases for over 20 years, including as co-lead counsel in over ten lawsuits that went to trial.
  • Holley has managed all aspects of patent litigation including pre-filing diligence, claim construction, fact and expert discovery, dispositive motions, and trial.

Michael J. Graff of Air Liquide Announced as Vice Chair of AIChE Foundation

Retrieved on: 
Tuesday, February 27, 2024

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The American Institute of Chemical Engineers (AIChE®) has announced the selection of Michael (Mike) J. Graff, Chairman and CEO of American Air Liquide Inc., and Executive Vice President of Air Liquide Group, as Vice Chair of the AIChE Foundation Board of Trustees.

Key Points: 
  • NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The American Institute of Chemical Engineers (AIChE®) has announced the selection of Michael (Mike) J. Graff, Chairman and CEO of American Air Liquide Inc., and Executive Vice President of Air Liquide Group, as Vice Chair of the AIChE Foundation Board of Trustees.
  • Graff joins a team led by Jennifer Sinclair Curtis, Distinguished Professor of Chemical Engineering at the University of California, Davis.
  • Graff began his term as Vice Chair in January 2024, and he will succeed Curtis as Foundation Chair in 2026.
  • For more information about the AIChE Foundation and its projects, visit www.aiche.org/giving.

Curia Appoints Steve Lavezoli as Vice President, Biologics

Retrieved on: 
Friday, February 23, 2024

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.

Key Points: 
  • ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.
  • Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.
  • “This is an exciting time for our biologics team, and we are pleased to have Steve on board,” said Curia CEO Philip Macnabb.
  • “Steve’s remarkable breadth of experience leading commercial operations for biologics development and manufacturing makes him a natural fit to lead our biologics efforts.

Timothy Go Elected to Celanese Board of Directors

Retrieved on: 
Wednesday, February 28, 2024

Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that Timothy Go has been elected to the company’s Board of Directors.

Key Points: 
  • Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that Timothy Go has been elected to the company’s Board of Directors.
  • Mr. Go, 57, is President, Chief Executive Officer, and a member of the Board of Directors of HF Sinclair Corporation.
  • He will begin his Board service effective immediately, bringing the total number of Board members to twelve (eleven of which are independent).
  • “We are delighted to have Tim join the Celanese Board, where his leadership experience in the energy and specialty chemical industries will enable him to bring an immensely valuable perspective,” said Lori Ryerkerk, Chair, Chief Executive Officer and President, Celanese Corporation.

BayWa r.e., Ampt and Fraunhofer ICT Complete European First-of-its-Kind PV, Wind and Battery Storage System Combination

Retrieved on: 
Tuesday, February 27, 2024

A 10 MWh flow battery energy storage system completes the triad.

Key Points: 
  • A 10 MWh flow battery energy storage system completes the triad.
  • Technically highly sophisticated, it represents a progressive plant combination of wind and solar energy including battery storage, which is unique in Europe in this form.
  • Through individual string MPPT, Ampt optimizers mitigate the energy losses caused by shade from surrounding buildings on the Fraunhofer ICT campus.
  • Our shareholders are BayWa AG, a €27,1 billion global business, and Energy Infrastructure Partners, a leader in energy infrastructure investment.

WasteFuel Strengthens Project Development Team With Appointment of Johan Fritz as Global Projects Director

Retrieved on: 
Tuesday, February 27, 2024

WasteFuel, a next-generation waste-to-fuels company, announced today that Johan Fritz, former Johnson Matthey Project and Engineering Director, will serve as the company’s Global Projects Director, effective May 1, 2024.

Key Points: 
  • WasteFuel, a next-generation waste-to-fuels company, announced today that Johan Fritz, former Johnson Matthey Project and Engineering Director, will serve as the company’s Global Projects Director, effective May 1, 2024.
  • Johan will oversee WasteFuel’s project development team and work alongside key partners to advance the company’s projects and accelerate WasteFuel’s efforts to produce green methanol at scale.
  • As the Project and Engineering Director at global chemical and sustainable technology company, Johnson Matthey, Johan was responsible for projects enabling net zero targets, managed the capex delivery of global projects, played a hands-on role in execution, and built and oversaw cross-stakeholder teams.
  • “I am looking forward to working alongside the WasteFuel team to build projects that will decarbonize shipping and reduce waste at this significant time for the company and the environment,” said Johan Fritz, Global Projects Director of WasteFuel.

Manulife announces additions to its Board of Directors

Retrieved on: 
Tuesday, March 5, 2024

He holds a Bachelor of Commerce from Saint Mary's University and a Ph.D. in Management from Queen's University.

Key Points: 
  • He holds a Bachelor of Commerce from Saint Mary's University and a Ph.D. in Management from Queen's University.
  • Mr. Kanak is a former senior executive with deep insurance experience in Asia.
  • He served in senior executive positions at American International Group (AIG) for over 14 years before joining Prudential.
  • "Mike, Don, Anna and John bring skills and experience critical to supporting the Board of Directors' effective oversight of Manulife given its growth ambitions and strategic priorities," said Don Lindsay, Chair of the Board, Manulife.